Luteolin as potential treatment for Huntington's disease: Insights from a transgenic mouse model.

Autor: Mohammed A; Department of Basic Medical Sciences, College of Medicine-Dar Al Uloom University, Riyadh, Saudi Arabia.; Department of Histology and Embryology, School of Basic Medical Sciences, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China., Ramadan A; College of Pharmacy, Al Ain University, Abu Dhbai, United Arab Emirates.; AAU Health and Biomedical Research Center, Al Ain University, Abu Dhabi, United Arab Emirates., Elnour AA; AAU Health and Biomedical Research Center, Al Ain University, Abu Dhabi, United Arab Emirates.; Program of Clinical Pharmacy, College of Pharmacy, Al Ain University, Abu Dhabi, United Arab Emirates., Saeed AAAM; Department of Pharmacology, Faculty of Clinical and Industrial Pharmacy, National University, Mycetoma Research Center, Khartoum, Sudan., Al Mazrouei N; Department of Pharmacy Practice and Pharmacotherapeutics, Faculty of Pharmacy, University of Sharjah, Sharjah, United Arab Emirates., Alsulami FT; Clinical Pharmacy Department, College of Pharmacy, Taif university, Taif, Saudi Arabia., Alqarni YS; Department of pharmacy practice, college of pharmacy, Imam abdulrahman bin faisal university, Dammam, Saudi Arabia., Menon V; Department of Pharmacy Practice, College of Pharmacy, Gulf Medical University, Ajman, United Arab Emirates., Amoodi AA; Ambulatory Healthcare Services, Academic Affairs, Abu Dhabi Health Services (SEHA), Abu Dhabi, United Arab Emirates., Abdalla SF; Clinical Department, College of Medicine, Almaarefa University (Diriyah), Riyadh, Saudi Arabia.

Publikováno v: CNS neuroscience & therapeutics [CNS Neurosci Ther] 2024 Sep; Vol. 30 (9), pp. e70025.